Goldman Sachs ActiveBeta International Equity ETF (GSIE)
| Assets | $5.83B |
| Expense Ratio | 0.25% |
| PE Ratio | 16.86 |
| Shares Out | 126.80M |
| Dividend (ttm) | $1.15 |
| Dividend Yield | 2.48% |
| Ex-Dividend Date | Mar 25, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 41.79% |
| Volume | 414,049 |
| Open | 46.30 |
| Previous Close | 46.32 |
| Day's Range | 46.30 - 46.53 |
| 52-Week Low | 38.53 |
| 52-Week High | 46.90 |
| Beta | 0.78 |
| Holdings | 660 |
| Inception Date | Nov 6, 2015 |
About GSIE
Fund Home PageThe Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of stocks in developed markets outside of the US comprising four sub-indices: value, momentum, quality and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight GSIE was launched on Nov 6, 2015 and is issued by Goldman Sachs.
Top 10 Holdings
10.66% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.50% |
| Royal Bank of Canada | RY | 1.10% |
| HSBC Holdings plc | HSBA | 1.07% |
| Novartis AG | NOVN | 0.99% |
| Roche Holding AG | ROP | 0.95% |
| Advantest Corporation | 6857 | 0.87% |
| Banco Santander, S.A. | SAN | 0.86% |
| AstraZeneca PLC | AZN | 0.81% |
| The Toronto-Dominion Bank | TD | 0.81% |
| Tokyo Electron Limited | 8035 | 0.70% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2026 | $0.1433 | Mar 31, 2026 |
| Dec 23, 2025 | $0.2187 | Dec 30, 2025 |
| Sep 24, 2025 | $0.22414 | Sep 30, 2025 |
| Jun 24, 2025 | $0.56325 | Jun 30, 2025 |
| Mar 25, 2025 | $0.13089 | Mar 31, 2025 |
| Dec 31, 2024 | $0.04259 | Jan 7, 2025 |
Performance
GSIE had a total return of 22.79% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.76%.
News
Goldman Sachs Hires New Model Portfolios Head
Model portfolios are a key pillar for asset managers competing for advisor and investor attention. They offer straightforward, pre-packaged tools that help investors target and achieve specific financ...